Ocera Therapeutics, Inc. — Operating Income by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d7896e29-a93d-4aed-82ae-549989bc3a07/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2012 | $-19.1M | 2012-01-01 – 2012-12-31 | evidence 0001274644-13-000008 |
| FY 2011 | $-20.7M | 2011-01-01 – 2011-12-31 | evidence 0001274644-12-000007 |
| FY 2010 | $-5.4M | 2010-01-01 – 2010-12-31 | evidence 0001274644-12-000007 |
| FY 2009 | $-10.0M | 2009-01-01 – 2009-12-31 | evidence 0001274644-12-000007 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).